Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03229863 · ClinicalTrials.gov registry record · NA

An Examination of Infants' Microbiome, Nutrition, and Development Study.

A NA study of Infant Development and Microbial Colonization, sponsored by University of California, Davis.

Active
Registry status
NA
Development phase
102
Enrollment target
1
Study location

NCT03229863: Active NA study of Infant Development and Microbial Colonization, sponsored by University of California, Davis.

NCT03229863 is a NA study of Infant Development and Microbial Colonization that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 102 participants, below the 400-participant average among 30 other Infant Development trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03229863, a NA study of Infant Development and Microbial Colonization, is active but no longer recruiting, sponsored by University of California, Davis.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
102 participants
Enrollment target
1
Study location

Study Summary

This study is examining the relationship between infant nutrition, gut health, and development. The fecal microbiota changes and develops, in large part due to the food that infants eat. These changes are important for many aspects of development. This study is designed to examine how the fecal microbiota changes when exclusively breastfed infants are first introduced to solid food, and how changes of the fecal microbiota are related to other aspects of development.

Primary Outcome

The difference in the relative abundance of the infant fecal microbiome at the order level (top 22 taxonomic orders with abundance expressed as both on log10 scale and a percent of total bacteria) between baseline and post-complementary food intake for each intervention arm (sweet potato vs. pear).

Interventions

  • OTHER Sweet Potatos
  • OTHER Pears

Study Locations (1)

California

  • University of California, Davis - Davis

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2017-04-18
Est. Completion 2027-03-10
Phase NA
University of California, Davis

657 total trials

What the registry record for NCT03229863 still lists

NCT03229863 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 400-participant average among 30 other Infant Development trials with a reported enrollment target (74% lower).

The record links to 2 conditions, with Infant Development appearing as the primary indexed condition, and to 2 interventions - of which Sweet Potatos is the first listed.

NCT03229863 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03229863 about?

NCT03229863 is a clinical study titled "An Examination of Infants' Microbiome, Nutrition, and Development Study.". This study is examining the relationship between infant nutrition, gut health, and development. The fecal microbiota changes and develops, in large part due to the food that infants eat. These changes are important for many aspects of development. This study is designed to examine how the fecal micr...

What is the current status of trial NCT03229863?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 102 participants. The study started on 2017-04-18. Estimated completion is 2027-03-10.

What conditions does trial NCT03229863 study?

This clinical trial studies the following conditions: Infant Development, Microbial Colonization.

What interventions are being tested in trial NCT03229863?

The interventions under investigation include: Sweet Potatos (OTHER), Pears (OTHER).

Who is sponsoring clinical trial NCT03229863?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03229863 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03229863's enrollment target sits among peer trials

102 17th of 30 higher than 14 of 30 other Infant Development trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infant Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03704662 · 102 participants · NA

    Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

  • NCT04174742 · 102 participants

    Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

  • NCT04275362 · 102 participants

    Gait Analysis of a Lateral-Pivot Design Total Knee Replacement

  • NCT04541082 · 102 participants · Phase 1

    Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03229863, the US trial registry maintained by the National Library of Medicine. NCT03229863 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.